World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
68
Citations
18114
World Ranking
2742
National Ranking
1283

Overview

Renaud La Joie is affiliated with the University of California, San Francisco in the United States. Their research contributions primarily focus on medical and neuroscience fields, with a strong emphasis on neurodegenerative disorders. The main areas of study include medicine and neuroscience, while subfields encompass psychiatry and mental health, physiology, cognitive neuroscience, radiology, nuclear medicine and imaging, and neurology.

The scientist's work covers the following main topics:

  • Alzheimer's disease research and treatments
  • Dementia and cognitive impairment research
  • Functional brain connectivity studies
  • Advanced neuroimaging techniques and applications
  • Medical imaging techniques and applications
  • Parkinson's disease mechanisms and treatments
  • Neurological disease mechanisms and treatments

Renaud La Joie has coauthored with several frequent collaborators, including Gil D. Rabinovici, Bruce L. Miller, Leonardo Iaccarino, David N. Soleimani-Meigooni, and Joel H. Kramer.

Their recent notable publications include:

  • Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET, 2020, Science Translational Medicine
  • Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration, 2020, Nature Medicine
  • Four distinct trajectories of tau deposition identified in Alzheimer's disease, 2021, Nature Medicine
  • Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study, 2021, The Lancet Neurology
  • Highly accurate blood test for Alzheimer's disease is similar or superior to clinical cerebrospinal fluid tests, 2024, Nature Medicine

Renaud La Joie's work has appeared in frequent publication venues such as:

  • Alzheimer s & Dementia
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Neurology
  • JAMA Neurology
  • Brain

Best Publications

  • Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.

    Alexandre Bejanin;Daniel R Schonhaut;Renaud La Joie;Joel H Kramer

  • Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration.

    Elisabeth H. Thijssen;Elisabeth H. Thijssen;Renaud La Joie;Amy Wolf;Amelia Strom

  • Four distinct trajectories of tau deposition identified in Alzheimer’s disease

    Jacob W Vogel;Alexandra L Young;Neil P Oxtoby;Ruben Smith

  • The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.

    Rik Ossenkoppele;Yolande A. L. Pijnenburg;David C. Perry;Brendan I. Cohn-Sheehy

  • Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET

    Renaud La Joie;Adrienne V. Visani;Suzanne L. Baker;Jesse A. Brown

  • Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study.

    Elisabeth H Thijssen;Renaud La Joie;Amelia Strom;Corrina Fonseca

  • Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease

    Anne Maass;Susan Landau;Suzanne L Baker;Andy Horng

  • Discriminative accuracy of [18F]flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders

    Rik Ossenkoppele;Rik Ossenkoppele;Gil D. Rabinovici;Ruben Smith;Hanna Cho

  • Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation

    Sylvia Villeneuve;Gil D. Rabinovici;Gil D. Rabinovici;Gil D. Rabinovici;Brendan I. Cohn-Sheehy;Brendan I. Cohn-Sheehy;Brendan I. Cohn-Sheehy;Cindee Madison

  • Why musical memory can be preserved in advanced Alzheimer’s disease

    Jörn Henrik Jacobsen;Jörn Henrik Jacobsen;Johannes Stelzer;Johannes Stelzer;Thomas Hans Fritz;Thomas Hans Fritz;Gael Chételat

  • Region-specific hierarchy between atrophy, hypometabolism, and β-amyloid (Aβ) load in Alzheimer's disease dementia.

    Renaud La Joie;Audrey Perrotin;Louisa Barré;Caroline Hommet;Caroline Hommet

  • Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease.

    Gaël Chételat;Renaud La Joie;Nicolas Villain;Audrey Perrotin

  • Structural imaging of hippocampal subfields in healthy aging and Alzheimer's disease

    Robin de Flores;Renaud La Joie;Gaël Chételat

  • Quantitative Comparison of 21 Protocols for Labeling Hippocampal Subfields and Parahippocampal Subregions in In Vivo MRI: Towards a Harmonized Segmentation Protocol

    Paul A. Yushkevich;Robert S C Amaral;Jean C. Augustinack;Andrew R. Bender

  • Relationships between years of education and gray matter volume, metabolism and functional connectivity in healthy elders

    Eider M. Arenaza-Urquijo;Brigitte Landeau;Renaud La Joie;Katell Mevel

  • Hippocampal subfield volumetry in mild cognitive impairment, Alzheimer's disease and semantic dementia.

    Renaud La Joie;Audrey Perrotin;Vincent de La Sayette;Stéphanie Egret

  • Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology

    Renaud La Joie;Nagehan Ayakta;Nagehan Ayakta;William W. Seeley;Ewa Borys

  • Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.

    Rik Ossenkoppele;Rik Ossenkoppele;Ruben Smith;Niklas Mattsson-Carlgren;Colin Groot

  • Longitudinal tau accumulation and atrophy in aging and alzheimer disease.

    Theresa M. Harrison;Renaud La Joie;Anne Maass;Anne Maass;Suzanne L. Baker

  • Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease

    Rik Ossenkoppele;Brendan I. Cohn-Sheehy;Renaud La Joie;Jacob W. Vogel

  • Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer’s disease

    Fanny M. Elahi;Kaitlin B. Casaletto;Renaud La Joie;Samantha M. Walters

Frequent Co-Authors

William J. Jagust
William J. Jagust University of California, Berkeley
Gaël Chételat
Gaël Chételat Université de Caen Normandie
Rik Ossenkoppele
Rik Ossenkoppele Lund University
Suzanne L. Baker
Suzanne L. Baker Lawrence Berkeley National Laboratory
Joel H. Kramer
Joel H. Kramer University of California, San Francisco
Francis Eustache
Francis Eustache Université de Caen Normandie
Béatrice Desgranges
Béatrice Desgranges Université de Caen Normandie
Vincent de la Sayette
Vincent de la Sayette Université de Caen Normandie
Brigitte Landeau
Brigitte Landeau Université de Caen Normandie
Maria Luisa Gorno-Tempini
Maria Luisa Gorno-Tempini University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Renaud La Joie

Trending Scientists

Recently Published Articles